Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Operating Expenses (2019 - 2025)

Korro Bio (KRRO) has disclosed Operating Expenses for 6 consecutive years, with $20.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Expenses fell 12.73% year-over-year to $20.3 million, compared with a TTM value of $101.9 million through Sep 2025, down 6.02%, and an annual FY2024 reading of $94.2 million, up 11.41% over the prior year.
  • Operating Expenses was $20.3 million for Q3 2025 at Korro Bio, down from $28.7 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $39.5 million in Q4 2023 and bottomed at -$5.8 million in Q4 2022.
  • Average Operating Expenses over 5 years is $22.4 million, with a median of $23.3 million recorded in 2022.
  • The sharpest move saw Operating Expenses tumbled 127.19% in 2022, then skyrocketed 780.56% in 2023.
  • Year by year, Operating Expenses stood at $21.4 million in 2021, then plummeted by 127.19% to -$5.8 million in 2022, then surged by 780.56% to $39.5 million in 2023, then crashed by 35.97% to $25.3 million in 2024, then decreased by 19.69% to $20.3 million in 2025.
  • Business Quant data shows Operating Expenses for KRRO at $20.3 million in Q3 2025, $28.7 million in Q2 2025, and $27.6 million in Q1 2025.